Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SFN | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | PFKM | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | HDHD3 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | MYL6B | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | PRADC1 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
mRNA | CNST | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | SLC16A6 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | NIPAL1 | CCLE | pan-cancer | AAC | 0.19 | 0.001 |
mRNA | GRHL3 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | ZNF552 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |